Charvin, Delphine
Medori, Rossella
Hauser, Robert A.
Rascol, Olivier
Article History
First Online: 28 September 2018
Change Date: 12 October 2018
Change Type: Correction
Change Details: In the original version of Figure 3, a dopamine D2 receptor had been positioned incorrectly and has now been moved to the correct presynaptic position on the dopaminergic neurons projecting to the basal ganglia motor circuit. In addition, the two Figure 2 citations that appeared on page 14 were incorrect and have now been changed to Figure 3.
Competing interests
: D.C. has received scientific grants from the Michael J. Fox Foundation (MJFF). D.C. and R.M. are members of the Management Team of Prexton Therapeutics. O.R. has received scientific grants from Agence Nationale de la Recherche, CHU de Toulouse, France-Parkinson, INSERM-DHOS Recherche Clinique Translationnelle, MJFF, Programme Hospitalier de Recherche Clinique and the European Commission (FP7, H2020). O.R. is a scientific adviser or consultant for AbbVie, Adamas Pharmaceuticals, Acorda Therapeutics, Addex Therapeutics, AlzProtect, ApoPharma, AstraZeneca, Bial, Biogen, Britannia, Clevexel, Cynapsus, INC Research, Lundbeck, Merck, MundiPharma, Neuroderm, Novartis, Oxford Biomedica, Parexel, Pfizer, Prexton Therapeutics, Quintiles, Sanofi, Servier, Teva, UCB, XenoPort and Zambon. R.A.H. reports consulting fees from Guidepoint Global, Gerson Lehrman Group, LCN Consulting, Putnam Associates, the National Parkinson Foundation, eResearch Technology, Inc., Lundbeck, Cynapsus, Sarepta Therapeutics, Adamas Pharmaceuticals, Neurocrine Biosciences, Back Bay Life Science, US WorldMeds, Biotie Therapies, MJFF, Neuropore Therapies, the US National Institutes of Health, Projects in Knowledge, Prexton Therapeutics, Acorda Therapeutics, Vista Research, LifeMax, Peerview Press, ClinicalMind Medical and Therapeutic Communications, Sunovion Pharmaceuticals, Inc., the Academy for Continued Healthcare Learning, Outcomes Insights, Expert Connect, HealthLogix, Teva, Cowen and Company, Pharma Two B, Ltd., Pfizer, RMEI Medical Education for Better Outcomes, ClearView Healthcare Partners, Health Advances, Kyowa Kirin Pharmaceutical Development, Ltd., Impax Laboratories, Quintiles, Pfizer, AbbVie, AstraZeneca, Eli Lilly & Company, Decision Resources Group, Seagrove Partners, LLC, Intec Pharma, Ltd., Schlesinger Associates, Huron Consulting Group, Pennside Partners, Bracket, Phase Five Communications, LCN Consulting and the Windrose Consulting Group.